230 related articles for article (PubMed ID: 28971440)
1. Probing Conformational Dynamics of Tau Protein by Hydrogen/Deuterium Exchange Mass Spectrometry.
Huang RY; Iacob RE; Sankaranarayanan S; Yang L; Ahlijanian M; Tao L; Tymiak AA; Chen G
J Am Soc Mass Spectrom; 2018 Jan; 29(1):174-182. PubMed ID: 28971440
[TBL] [Abstract][Full Text] [Related]
2. Understanding molecular features of aggregation-resistant tau conformer using oxidized monomer.
Jebarupa B; Mathew B; Srinivasu BY; Sasikumaran A; Joseph S; Mandal AK; Thomas T; Mitra G
Biochim Biophys Acta Gen Subj; 2019 Jun; 1863(6):993-1005. PubMed ID: 30853336
[TBL] [Abstract][Full Text] [Related]
3. Contemporary hydrogen deuterium exchange mass spectrometry.
Oganesyan I; Lento C; Wilson DJ
Methods; 2018 Jul; 144():27-42. PubMed ID: 29704663
[TBL] [Abstract][Full Text] [Related]
4. Difference in fibril core stability between two tau four-repeat domain proteins: a hydrogen-deuterium exchange coupled to mass spectrometry study.
Ramachandran G; Udgaonkar JB
Biochemistry; 2013 Dec; 52(49):8787-9. PubMed ID: 24256615
[TBL] [Abstract][Full Text] [Related]
5. Conformational analysis of g protein-coupled receptor signaling by hydrogen/deuterium exchange mass spectrometry.
Li S; Lee SY; Chung KY
Methods Enzymol; 2015; 557():261-78. PubMed ID: 25950969
[TBL] [Abstract][Full Text] [Related]
6. Hyperphosphorylation of intrinsically disordered tau protein induces an amyloidogenic shift in its conformational ensemble.
Zhu S; Shala A; Bezginov A; Sljoka A; Audette G; Wilson DJ
PLoS One; 2015; 10(3):e0120416. PubMed ID: 25767879
[TBL] [Abstract][Full Text] [Related]
7. Hydrogen/deuterium exchange mass spectrometry and computational modeling reveal a discontinuous epitope of an antibody/TL1A Interaction.
Huang RY; Krystek SR; Felix N; Graziano RF; Srinivasan M; Pashine A; Chen G
MAbs; 2018 Jan; 10(1):95-103. PubMed ID: 29135326
[TBL] [Abstract][Full Text] [Related]
8. Higher order structure characterization of protein therapeutics by hydrogen/deuterium exchange mass spectrometry.
Huang RY; Chen G
Anal Bioanal Chem; 2014 Oct; 406(26):6541-58. PubMed ID: 24948090
[TBL] [Abstract][Full Text] [Related]
9. Effects of tau domain-specific antibodies and intravenous immunoglobulin on tau aggregation and aggregate degradation.
Esteves-Villanueva JO; Trzeciakiewicz H; Loeffler DA; Martić S
Biochemistry; 2015 Jan; 54(2):293-302. PubMed ID: 25545358
[TBL] [Abstract][Full Text] [Related]
10. Suppressing allostery in epitope mapping experiments using millisecond hydrogen / deuterium exchange mass spectrometry.
Deng B; Zhu S; Macklin AM; Xu J; Lento C; Sljoka A; Wilson DJ
MAbs; 2017; 9(8):1327-1336. PubMed ID: 28933661
[TBL] [Abstract][Full Text] [Related]
11. A 31-residue peptide induces aggregation of tau's microtubule-binding region in cells.
Stöhr J; Wu H; Nick M; Wu Y; Bhate M; Condello C; Johnson N; Rodgers J; Lemmin T; Acharya S; Becker J; Robinson K; Kelly MJS; Gai F; Stubbs G; Prusiner SB; DeGrado WF
Nat Chem; 2017 Sep; 9(9):874-881. PubMed ID: 28837163
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation-mimicking glutamate clusters in the proline-rich region are sufficient to simulate the functional deficiencies of hyperphosphorylated tau protein.
Eidenmüller J; Fath T; Maas T; Pool M; Sontag E; Brandt R
Biochem J; 2001 Aug; 357(Pt 3):759-67. PubMed ID: 11463346
[TBL] [Abstract][Full Text] [Related]
13. Conformational Assessment of Adnectin and Adnectin-Drug Conjugate by Hydrogen/Deuterium Exchange Mass Spectrometry.
Huang RY; O'Neil SR; Lipovšek D; Chen G
J Am Soc Mass Spectrom; 2018 Jul; 29(7):1524-1531. PubMed ID: 29736601
[TBL] [Abstract][Full Text] [Related]
14. Independent tubulin binding and polymerization by the proline-rich region of Tau is regulated by Tau's N-terminal domain.
McKibben KM; Rhoades E
J Biol Chem; 2019 Dec; 294(50):19381-19394. PubMed ID: 31699899
[TBL] [Abstract][Full Text] [Related]
15. Differential effect of phosphorylation and substrate modulation on tau's ability to promote microtubule growth and nucleation.
Brandt R; Lee G; Teplow DB; Shalloway D; Abdel-Ghany M
J Biol Chem; 1994 Apr; 269(16):11776-82. PubMed ID: 8163474
[TBL] [Abstract][Full Text] [Related]
16. Structural impact of heparin binding to full-length Tau as studied by NMR spectroscopy.
Sibille N; Sillen A; Leroy A; Wieruszeski JM; Mulloy B; Landrieu I; Lippens G
Biochemistry; 2006 Oct; 45(41):12560-72. PubMed ID: 17029411
[TBL] [Abstract][Full Text] [Related]
17. An overview of hydrogen deuterium exchange mass spectrometry (HDX-MS) in drug discovery.
Masson GR; Jenkins ML; Burke JE
Expert Opin Drug Discov; 2017 Oct; 12(10):981-994. PubMed ID: 28770632
[TBL] [Abstract][Full Text] [Related]
18. Determination of Binding Sites on Trastuzumab and Pertuzumab to Selective Affimers Using Hydrogen-Deuterium Exchange Mass Spectrometry.
Olaleye O; Graf C; Spanov B; Govorukhina N; Groves MR; van de Merbel NC; Bischoff R
J Am Soc Mass Spectrom; 2023 Apr; 34(4):775-783. PubMed ID: 36960982
[TBL] [Abstract][Full Text] [Related]
19. Hydrogen/deuterium exchange-mass spectrometry analysis of high concentration biotherapeutics: application to phase-separated antibody formulations.
Tian Y; Huang L; Ruotolo BT; Wang N
MAbs; 2019; 11(4):779-788. PubMed ID: 30890021
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Aggregation Propensity of a Human Fc-Fusion Protein Therapeutic by Hydrogen/Deuterium Exchange Mass Spectrometry.
Huang RY; Iacob RE; Krystek SR; Jin M; Wei H; Tao L; Das TK; Tymiak AA; Engen JR; Chen G
J Am Soc Mass Spectrom; 2017 May; 28(5):795-802. PubMed ID: 27527097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
